Page

Name

E-mail

Message

2025-11-29

#reports #QGEN

[QIAGEN](https://eninvs.com/all.php?name=QGEN) (Medicines services provider) reported for 2025 q3
(2025-11-04, After Market Close):

- Revenue +6.2% YoY (vs +7.7% in previous quarter and historical rate -1.8%)
- EBITDA +11.1% YoY (vs +17000.0% in previous quarter and historical rate +13.5%)
- EBITDA margin 33.8% increased compared to 32.3% same period last year
- Net Debt decreased by $53 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 16.4x compared to historical level (75th percentile) of 32.3x
- EV/Sales multiple is 5.3x

The company showed EPS +$0.6 per share. At the opening of the session the share price went down -1.7% vs S&P500 -0.1%

------------------------------------------------

2025-11-29

#reports #HCTI

[Healthcare Triangle, Inc.](https://eninvs.com/all.php?name=HCTI) (Health Information Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194411)
(2025-11-13, Before Market Open):

- Revenue +50% YoY (vs +33.3% in previous quarter and historical rate -27.1%)
- EBITDA margin -100.0% decreased compared to -50.0% same period last year
- Net Debt decreased by $7 mln over the past reporting period (133.4% of market cap)
- FCF (LTM) -$0 bln (negative), 38.1% of market cap
- EV/Sales multiple is 0.2x

The company showed EPS -$89.92 per share. At the opening of the session the share price went down -2.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-29

#reports #FFIV

[F5 Networks](https://eninvs.com/all.php?name=FFIV) (Maintains websites and applications) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194422)
(2025-10-27, After Market Close):

- Revenue -71.7% YoY (vs +12.2% in previous quarter and historical rate +14.3%)
- EBITDA -61.3% YoY (vs +15.3% in previous quarter and historical rate +29.7%)
- EBITDA margin 28.4% increased compared to 20.8% same period last year
- Net Debt increased by $84 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.5 bln (positive), 3.2% of market cap
- EV/EBITDA multiple is 15.6x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 4.3x

The company showed EPS +$3.26 per share. At the opening of the session the share price went down -9.7% vs S&P500 +0.3%

------------------------------------------------

2025-11-27

#reports #LI
@ china , @ electric-vehicles

[Li Auto](https://eninvs.com/all.php?name=LI) (Vehicles manufacturer) reported for 2025 q3
(2025-11-26, Before Market Open):

- Revenue -37.1% YoY (vs +40.6% in previous quarter and historical rate +62.1%)
- EBITDA -121.5% YoY (vs +78.5% in previous quarter and historical rate +65.0%)
- EBITDA margin -3.0% decreased compared to 8.7% same period last year
- Net Debt decreased by $454 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0.4 bln (positive), 2.1% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 29.2x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -2.0% vs S&P500 +0.4%

------------------------------------------------

2025-11-26

#reports #TITN

[Titan Machinery](https://eninvs.com/all.php?name=TITN) (Industrial Distribution) reported for 2025 q3
(2025-11-25, Before Market Open):

- Revenue -5.1% YoY (vs -13.9% in previous quarter and historical rate +7.4%)
- EBITDA -9.1% YoY (vs -60.0% in previous quarter and historical rate -29.8%)
- EBITDA margin 3.1% decreased compared to 3.2% same period last year
- Net Debt decreased by $10 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 14.3% of market cap
- EV/Sales multiple is 0.3x

The company showed EPS +$0.05 per share. At the opening of the session the share price went up +3.4% vs S&P500 -0.1%

------------------------------------------------

2025-11-26

#reports #SJM

[JM Smucker](https://eninvs.com/all.php?name=SJM) (Food manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194405)
(2025-11-25, Before Market Open):

- Revenue +2.6% YoY (vs -0.6% in previous quarter and historical rate +2.8%)
- EBITDA +88.6% YoY (vs -62.2% in previous quarter and historical rate -20.6%)
- EBITDA margin 24.1% increased compared to 13.1% same period last year
- Net Debt decreased by $190 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.7% of market cap
- EV/Sales multiple is 2.1x

The company showed EPS +$2.26 per share. At the opening of the session the share price went down -3.7% vs S&P500 -0.1%

------------------------------------------------

2025-11-26

#reports #PD

[PagerDuty](https://eninvs.com/all.php?name=PD) (Software provider) reported for 2025 q3
(2025-11-25, After Market Close):

- Revenue +5% YoY (vs +6.0% in previous quarter and historical rate +12.3%)
- EBITDA margin 6.4% increased compared to -8.4% same period last year
- Net Debt increased by $23 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 47.6x compared to historical level (75th percentile) of 1367x
- EV/Sales multiple is 2.6x

The company showed EPS +$1.7 per share

------------------------------------------------

2025-11-26

#reports #KSS

[Kohls](https://eninvs.com/all.php?name=KSS) (Department Stores) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=KSS&q=2025 q3&id=903207)
(2025-11-25, Before Market Open):

- Revenue -3.6% YoY (vs -5.0% in previous quarter and historical rate -5.2%)
- EBITDA -11.7% YoY (vs +28.2% in previous quarter and historical rate -1.5%)
- EBITDA margin 7.0% decreased compared to 7.6% same period last year
- Net Debt decreased by $24 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.6 bln (positive), 19.9% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 0.6x

The company showed EPS +$0.07 per share. At the opening of the session the share price went up +23.9% vs S&P500 -0.1%

------------------------------------------------

2025-11-26

#reports #CLFD

[Clearfield](https://eninvs.com/all.php?name=CLFD) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194401)
(2025-11-25, Before Market Open):

- Revenue -61.7% YoY (vs +2.0% in previous quarter and historical rate -10.1%)
- EBITDA margin 22.2% increased compared to -4.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 2.6% of market cap
- EV/EBITDA multiple is 48.5x compared to historical level (75th percentile) of 24.1x
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -13.0% vs S&P500 -0.1%

------------------------------------------------

2025-11-26

#reports #AMBA

[Ambarella](https://eninvs.com/all.php?name=AMBA) (Semiconductor manufacturer) reported for 2025 q3
(2025-11-25, After Market Close):

- Revenue +30.1% YoY (vs +50.0% in previous quarter and historical rate +9.6%)
- EBITDA margin -9.3% increased compared to -22.9% same period last year
- Net Debt decreased by $21 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/Sales multiple is 9.9x

The company showed EPS -$0.35 per share

------------------------------------------------

2025-11-26

#reports #ADSK

[Autodesk](https://eninvs.com/all.php?name=ADSK) ( PC software and multimedia tools provider) reported for 2025 q3
(2025-11-25, After Market Close):

- Revenue +18% YoY (vs +17.1% in previous quarter and historical rate +12.0%)
- EBITDA +19.3% YoY (vs +14.1% in previous quarter and historical rate +15.2%)
- EBITDA margin 25.4% increased compared to 25.1% same period last year
- Net Debt decreased by $53 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.3% of market cap
- EV/EBITDA multiple is 42.1x compared to historical level (75th percentile) of 45.2x
- EV/Sales multiple is 9.5x

The company showed EPS +$1.6 per share

------------------------------------------------

2025-11-26

#reports #ZS
@ cybersecurity , @ saas

[Zscaler](https://eninvs.com/all.php?name=ZS) (Internet security platform) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194406)
(2025-11-25, After Market Close):

- Revenue +25.5% YoY (vs +21.2% in previous quarter and historical rate +33.1%)
- EBITDA -220% YoY (vs +303.6% in previous quarter and historical rate +87.3%)
- EBITDA margin -4.6% decreased compared to 4.8% same period last year
- Net Debt increased by $289 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 571x compared to historical level (75th percentile) of 905.8x
- EV/Sales multiple is 15.3x

The company showed EPS -$0.07 per share

------------------------------------------------

2025-11-26

#reports #WDAY
@ artificial-intelligence , @ saas

[Workday](https://eninvs.com/all.php?name=WDAY) (Enterprise cloud-based applications provider) reported for 2025 q3
(2025-11-25, After Market Close):

- Revenue +12.6% YoY (vs +12.6% in previous quarter and historical rate +15.8%)
- EBITDA +35.2% YoY (vs +59.1% in previous quarter and historical rate +80.6%)
- EBITDA margin 17.2% increased compared to 14.4% same period last year
- Net Debt increased by $1.4 bln since the start of the year (2.3% of market cap)
- FCF (LTM) +$0.7 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 45.9x compared to historical level (75th percentile) of 137.4x
- EV/Sales multiple is 6.2x

The company showed EPS +$0.94 per share

------------------------------------------------

2025-11-26

#reports #BABA
@ china , @ e-commerce

[Alibaba](https://eninvs.com/all.php?name=BABA) (Chinese e-commerce giant) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BABA&q=2025 q3&id=903107)
(2025-11-25, Before Market Open):

- Revenue +3.3% YoY (vs +3.3% in previous quarter and historical rate +2.8%)
- EBITDA -66.7% YoY (vs -1.7% in previous quarter and historical rate +17.2%)
- EBITDA margin 6.0% decreased compared to 18.5% same period last year
- Net Debt increased by $11.4 bln since the start of the year (2.8% of market cap)
- FCF (LTM) -$12.4 bln (negative), 3.0% of market cap
- EV/EBITDA multiple is 19.5x compared to historical level (75th percentile) of 12x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +2.8% vs S&P500 -0.1%

------------------------------------------------

2025-11-25

#reports #KEYS

[Keysight Technologies](https://eninvs.com/all.php?name=KEYS) (Test equipment manufacturer) reported for 2025 q3
(2025-11-24, After Market Close):

- Revenue +10.3% YoY (vs +11.1% in previous quarter and historical rate +0.1%)
- EBITDA -2% YoY (vs -12.6% in previous quarter and historical rate -10.6%)
- EBITDA margin 20.6% decreased compared to 23.2% same period last year
- Net Debt increased by $777 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 30.3x compared to historical level (75th percentile) of 25.7x
- EV/Sales multiple is 6.1x

The company showed EPS +$1.32 per share

------------------------------------------------

2025-11-25

#reports #ZM
@ cloud-computing , @ saas

[Zoom Video Communications](https://eninvs.com/all.php?name=ZM) (Group video conferencing platform) reported for 2025 q3
(2025-11-24, After Market Close):

- Revenue +4.4% YoY (vs +4.6% in previous quarter and historical rate +3.4%)
- EBITDA +47.6% YoY (vs +40.1% in previous quarter and historical rate +45.9%)
- EBITDA margin 32.3% increased compared to 22.8% same period last year
- Net Debt decreased by $168 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 10.7x compared to historical level (75th percentile) of 25.3x
- EV/Sales multiple is 3.3x

The company showed EPS +$2 per share

------------------------------------------------

2025-11-22

#reports #POLA

[Polar Power](https://eninvs.com/all.php?name=POLA) (Electrical Equipment and Parts) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194379)
(2025-08-14):

- Revenue -80% YoY (vs -40.0% in previous quarter and historical rate +0.4%)
- EBITDA margin -400.0% decreased compared to 0.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (18.4% of market cap)
- EV/Sales multiple is 1.3x

The company showed EPS -$1.63 per share

------------------------------------------------

2025-11-22

#reports #RERE

[ATRenew Inc.](https://eninvs.com/all.php?name=RERE) (Internet Retail) reported for 2025 q3
(2025-08-20, Before Market Open):

- Revenue +27% YoY (vs +35.9% in previous quarter and historical rate +26.8%)
- EBITDA +325% YoY (vs +1000.0% in previous quarter and historical rate +66.7%)
- EBITDA margin 2.6% increased compared to 0.8% same period last year
- Net Debt decreased by $39 mln over the past reporting period (5.9% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 71x
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +2.8% vs S&P500 0.0%

------------------------------------------------

2025-11-22

#reports #MATW

[Matthews International](https://eninvs.com/all.php?name=MATW) (Memorialization products manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194354)
(2025-11-20, After Market Close):

- Revenue -28.6% YoY (vs -18.5% in previous quarter and historical rate -4.8%)
- EBITDA margin 1.3% increased compared to -5.6% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 7.0% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 20.6x
- EV/Sales multiple is 1x

The company showed EPS -$0.88 per share. At the opening of the session the share price went up +1.2% vs S&P500 +0.2%

------------------------------------------------

2025-11-22

#reports #LANC

[Lancaster Colony](https://eninvs.com/all.php?name=LANC) (Food products provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194339)
(2025-04-30, Before Market Open):

- Revenue +5.6% YoY (vs +3.6% in previous quarter and historical rate +21.2%)
- EBITDA +6.8% YoY (vs +5.2% in previous quarter and historical rate +44.5%)
- EBITDA margin 12.8% increased compared to 12.6% same period last year
- Net Debt decreased by $22 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 10.8x compared to historical level (75th percentile) of 16.2x
- EV/Sales multiple is 1.6x

The company showed EPS +$1.71 per share. At the opening of the session the share price went down -17.0% vs S&P500 -1.1%

------------------------------------------------

2025-11-22

#reports #DOX

[Amdocs](https://eninvs.com/all.php?name=DOX) (Software — Infrastructure) reported for 2025 q3
(2025-11-11, After Market Close):

- Revenue -9% YoY (vs -8.5% in previous quarter and historical rate -0.1%)
- EBITDA +14.8% YoY (vs +13.5% in previous quarter and historical rate +2.1%)
- EBITDA margin 16.2% increased compared to 12.8% same period last year
- Net Debt decreased by $70 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 12.9x
- EV/Sales multiple is 2x

The company showed EPS +$0.88 per share. At the opening of the session the share price went down -2.0% vs S&P500 +0.3%

------------------------------------------------

2025-11-22

#reports #YSG
@ china

[Yatsen](https://eninvs.com/all.php?name=YSG) (Specialty Retail) reported for 2025 q3
(2025-11-17, Before Market Open):

- Revenue +45.8% YoY (vs +39.4% in previous quarter and historical rate +0.9%)
- EBITDA margin -2.1% increased compared to -11.5% same period last year
- Net Debt increased by $44 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 2.2x compared to historical level (75th percentile) of 1.6x
- EV/Sales multiple is 6x

The company showed EPS -$0.7 per share. At the opening of the session the share price went down -2.0% vs S&P500 -0.3%

------------------------------------------------

2025-11-22

#reports #DOYU
@ china

[DouYu International](https://eninvs.com/all.php?name=DOYU) ( Entertainment services provider) reported for 2025 q3
(2025-08-18, Before Market Open):

- Revenue -16.6% YoY (vs +3.5% in previous quarter and historical rate -19.4%)
- EBITDA margin 3.2% increased compared to -7.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.3% of market cap
- EV/Sales multiple is 3.5x

At the opening of the session the share price went up +7.5% vs S&P500 -0.1%

------------------------------------------------

2025-11-21

#reports #VEEV

[Veeva Systems](https://eninvs.com/all.php?name=VEEV) (Software provider) reported for 2025 q3
(2025-11-20, After Market Close):

- Revenue +16% YoY (vs +16.7% in previous quarter and historical rate +14.1%)
- EBITDA +32.1% YoY (vs +17.4% in previous quarter and historical rate +27.8%)
- EBITDA margin 30.5% increased compared to 26.8% same period last year
- Net Debt decreased by $230 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$1.3 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 42.7x compared to historical level (75th percentile) of 63.1x
- EV/Sales multiple is 12.2x

The company showed EPS +$1.4 per share

------------------------------------------------

2025-11-21

#reports #ROAD

[Construction Partners](https://eninvs.com/all.php?name=ROAD) (Engineering and Construction) reported for 2025 q3
(2025-11-20, Before Market Open):

- Revenue +67.3% YoY (vs +50.4% in previous quarter and historical rate +30.4%)
- EBITDA +129.5% YoY (vs +131.9% in previous quarter and historical rate +77.3%)
- EBITDA margin 24.2% increased compared to 17.7% same period last year
- Net Debt increased by $145 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) -$0.9 bln (negative), 16.4% of market cap
- EV/EBITDA multiple is 14.5x compared to historical level (75th percentile) of 22.2x
- EV/Sales multiple is 2.5x

The company showed EPS +$1.02 per share. At the opening of the session the share price went down -3.9% vs S&P500 +1.3%

------------------------------------------------

2025-11-21

#reports #POST

[Post](https://eninvs.com/all.php?name=POST) (Consumer packaged goods provider) reported for 2025 q3
(2025-11-20, After Market Close):

- Revenue +11.8% YoY (vs +1.8% in previous quarter and historical rate +10.3%)
- EBITDA -11.9% YoY (vs +14.2% in previous quarter and historical rate +13.9%)
- EBITDA margin 10.6% decreased compared to 13.4% same period last year
- Net Debt increased by $712 mln over the past reporting period (11.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 2.7% of market cap
- EV/EBITDA multiple is 10.9x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 2.1x

The company showed EPS +$0.88 per share

------------------------------------------------

2025-11-21

#reports #INTU

[Intuit](https://eninvs.com/all.php?name=INTU) (Software developer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194332)
(2025-11-20, After Market Close):

- Revenue +18.3% YoY (vs +20.3% in previous quarter and historical rate +14.1%)
- EBITDA +83.5% YoY (vs +38100.0% in previous quarter and historical rate +21.7%)
- EBITDA margin 14.9% increased compared to 9.6% same period last year
- Net Debt increased by $905 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.9 bln (positive), 0.5% of market cap
- EV/EBITDA multiple is 33.6x compared to historical level (75th percentile) of 47x
- EV/Sales multiple is 9.3x

The company showed EPS +$1.59 per share

------------------------------------------------

2025-11-21

#reports #ESTC

[Elastic](https://eninvs.com/all.php?name=ESTC) (Information technology service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ESTC&q=2025 q3&id=902791)
(2025-11-20, After Market Close):

- Revenue +15.9% YoY (vs +19.6% in previous quarter and historical rate +18.1%)
- EBITDA -4.3% YoY (vs +1800.0% in previous quarter and historical rate +83.0%)
- EBITDA margin 5.2% decreased compared to 6.3% same period last year
- Net Debt increased by $95 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 100.3x compared to historical level (75th percentile) of 396.4x
- EV/Sales multiple is 4.9x

The company showed EPS -$0.48 per share

------------------------------------------------

2025-11-21

#reports #ATKR

[Atkore](https://eninvs.com/all.php?name=ATKR) (Cable ducts for electrical wiring manufacturer ) reported for 2025 q3
(2025-11-20, Before Market Open):

- Revenue -76.5% YoY (vs -10.6% in previous quarter and historical rate +1.6%)
- EBITDA -90.9% YoY (vs -45.0% in previous quarter and historical rate -23.6%)
- EBITDA margin 9.0% decreased compared to 23.3% same period last year
- Net Debt decreased by $182 mln over the past reporting period (7.6% of market cap)
- FCF (LTM) -$0.6 bln (negative), 25.1% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 5.8x
- EV/Sales multiple is 1x

The company showed EPS -$1.62 per share. At the opening of the session the share price went down -2.8% vs S&P500 +1.3%

------------------------------------------------

2025-11-21

#reports #VIPS
@ china

[Vipshop](https://eninvs.com/all.php?name=VIPS) (E-commerce platform) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=VIPS&q=2025 q3&id=902893)
(2025-11-20, Before Market Open):

- Revenue +1.9% YoY (vs -2.6% in previous quarter and historical rate 0.0%)
- EBITDA -4.5% YoY (vs -24.3% in previous quarter and historical rate +11.7%)
- EBITDA margin 5.6% decreased compared to 6.0% same period last year
- Net Debt decreased by $61 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 7.5x
- EV/Sales multiple is 0.6x

At the opening of the session the share price went down -4.3% vs S&P500 +1.3%

------------------------------------------------

2025-11-21

#reports #NTES
@ china

[NetEase](https://eninvs.com/all.php?name=NTES) (IT services and products provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=NTES&q=2025 q3&id=902860)
(2025-11-20, Before Market Open):

- Revenue +6.7% YoY (vs +11.0% in previous quarter and historical rate +5.5%)
- EBITDA +10.9% YoY (vs +26.3% in previous quarter and historical rate +13.4%)
- EBITDA margin 30.4% increased compared to 29.3% same period last year
- Net Debt decreased by $982 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$3.7 bln (positive), 4.1% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 14.4x
- EV/Sales multiple is 4.5x

At the opening of the session the share price went down -2.3% vs S&P500 +1.3%

------------------------------------------------

2025-11-20

#reports #UTI

[Universal Technical Institute](https://eninvs.com/all.php?name=UTI) (Education and Training Services) reported for 2025 q3
(2025-11-19, After Market Close):

- Revenue -40.2% YoY (vs +15.3% in previous quarter and historical rate +31.2%)
- EBITDA -31.3% YoY (vs +22.2% in previous quarter and historical rate +59.2%)
- EBITDA margin 14.9% increased compared to 12.9% same period last year
- Net Debt decreased by $39 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.7% of market cap
- EV/EBITDA multiple is 14.5x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 2.1x

The company showed EPS +$0.34 per share

------------------------------------------------

2025-11-20

#reports #GLBE

[Global-e Online Ltd.](https://eninvs.com/all.php?name=GLBE) (Internet Retail) reported for 2025 q3
(2025-11-19, Before Market Open):

- Revenue +25.6% YoY (vs +28.0% in previous quarter and historical rate +34.0%)
- EBITDA margin 8.1% increased compared to -11.4% same period last year
- Net Debt decreased by $37 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 3.5% of market cap
- EV/Sales multiple is 5.6x

The company showed EPS +$0.07 per share. At the opening of the session the share price went down -0.6% vs S&P500 -0.1%

------------------------------------------------

2025-11-20

#reports #PANW
@ cybersecurity

[Palo Alto Networks](https://eninvs.com/all.php?name=PANW) (Cybersecurity company) reported for 2025 q3
(2025-11-19, After Market Close):

- Revenue +15.7% YoY (vs +15.8% in previous quarter and historical rate +18.1%)
- EBITDA +6.3% YoY (vs +97.0% in previous quarter and historical rate +95.8%)
- EBITDA margin 15.7% decreased compared to 17.1% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (1.0% of market cap)
- FCF (LTM) +$0.2 bln (positive), 0.2% of market cap
- EV/EBITDA multiple is 82.5x compared to historical level (75th percentile) of 126.9x
- EV/Sales multiple is 13.3x

The company showed EPS +$0.47 per share

------------------------------------------------

2025-11-19

#reports #VREX

[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194325)
(2025-11-18, After Market Close):

- Revenue +11.2% YoY (vs -2.9% in previous quarter and historical rate -0.3%)
- EBITDA +40.9% YoY (vs -473.7% in previous quarter and historical rate -16.1%)
- EBITDA margin 13.5% increased compared to 10.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 6.7% of market cap
- EV/EBITDA multiple is 104.4x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 0.9x

The company showed EPS +$0.29 per share

------------------------------------------------

2025-11-19

#reports #ESLT

[Elbit Systems](https://eninvs.com/all.php?name=ESLT) (Aerospace and Defense) reported for 2025 q3
(2025-11-18, Before Market Open):

- Revenue +11.9% YoY (vs +21.3% in previous quarter and historical rate +12.2%)
- EBITDA +30.3% YoY (vs +29.7% in previous quarter and historical rate +17.8%)
- EBITDA margin 11.2% increased compared to 9.6% same period last year
- Net Debt decreased by $200 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 29.5x compared to historical level (75th percentile) of 26.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +3.9% vs S&P500 -0.4%

------------------------------------------------

2025-11-19

#reports #BRBR

[BellRing Brands](https://eninvs.com/all.php?name=BRBR) (Packaged Foods) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=BRBR&q=2025 q3&id=902611)
(2025-11-18, Before Market Open):

- Revenue +16.5% YoY (vs +6.4% in previous quarter and historical rate +19.3%)
- EBITDA -9% YoY (vs -56.8% in previous quarter and historical rate +30.0%)
- EBITDA margin 15.6% decreased compared to 20.0% same period last year
- Net Debt increased by $48 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 28.6x
- EV/Sales multiple is 2x

The company showed EPS +$0.48 per share. At the opening of the session the share price went down -4.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-18

#reports #ZYXI

[Zynex](https://eninvs.com/all.php?name=ZYXI) (Medical equipment manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194320)
(2025-11-17, After Market Close):

- Revenue -74% YoY (vs -56.0% in previous quarter and historical rate -4.8%)
- EBITDA -960% YoY (vs -400.0% in previous quarter and historical rate -66.8%)
- EBITDA margin -330.8% decreased compared to 10.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (17.5% of market cap)
- FCF (LTM) -$0 bln (negative), 122.8% of market cap
- EV/Sales multiple is 0.7x

The company showed EPS -$1.42 per share

------------------------------------------------

2025-11-18

#reports #ENTA

[Enanta Pharmaceuticals](https://eninvs.com/all.php?name=ENTA) (Small molecular drugs manufacturer) reported for 2025 q3
(2025-11-17, After Market Close):

- Revenue -54.5% YoY (vs 0.0% in previous quarter and historical rate -4.9%)
- EBITDA margin -353.3% decreased compared to -193.9% same period last year
- Net Debt increased by $15 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0 bln (negative), 16.8% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-11-18

#reports #BRC

[Brady Corporation](https://eninvs.com/all.php?name=BRC) ( Identification products manufacturer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194318)
(2025-11-17, Before Market Open):

- Revenue +7.4% YoY (vs +15.7% in previous quarter and historical rate +16.6%)
- EBITDA +14.5% YoY (vs -5.4% in previous quarter and historical rate +17.1%)
- EBITDA margin 19.5% increased compared to 18.3% same period last year
- Net Debt increased by $10 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 11.7x compared to historical level (75th percentile) of 12.3x
- EV/Sales multiple is 2.2x

The company showed EPS +$1.11 per share. At the opening of the session the share price went up +2.8% vs S&P500 -0.3%

------------------------------------------------

2025-11-18

#reports #ARMK

[Aramark](https://eninvs.com/all.php?name=ARMK) (Catering, Facility and Human Resources Service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=ARMK&q=2025 q3&id=902456)
(2025-11-17, Before Market Open):

- Revenue +14.3% YoY (vs +109.8% in previous quarter and historical rate +10.5%)
- EBITDA +75% YoY (vs +136.7% in previous quarter and historical rate +17.1%)
- EBITDA margin 11.5% increased compared to 7.5% same period last year
- Net Debt decreased by $1 bln since the start of the year (10.8% of market cap)
- FCF (LTM) -$1.2 bln (negative), 12.6% of market cap
- EV/EBITDA multiple is 7.9x compared to historical level (75th percentile) of 13.3x
- EV/Sales multiple is 0.6x

The company showed EPS +$0.33 per share. At the opening of the session the share price went down -5.8% vs S&P500 -0.3%

------------------------------------------------

2025-11-18

#reports #SOHU
@ china

[Sohu.com](https://eninvs.com/all.php?name=SOHU) (Online advertising service provider) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SOHU&q=2025 q3&id=902467)
(2025-11-17, Before Market Open):

- Revenue +18.4% YoY (vs -26.7% in previous quarter and historical rate -8.3%)
- EBITDA +3.3% YoY (vs -2300.0% in previous quarter and historical rate -48.0%)
- EBITDA margin 469.4% decreased compared to 538.2% same period last year
- Net Debt decreased by $48 mln over the past reporting period (9.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 20.6% of market cap
- EV/Sales multiple is -0.6x

At the opening of the session the share price went up +4.7% vs S&P500 -0.3%

------------------------------------------------

2025-11-15

#reports #VNRX

[VolitionRx Limited](https://eninvs.com/all.php?name=VNRX) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194251)
(2025-11-13, After Market Close):

- Revenue +32% YoY (vs +2.8% in previous quarter and historical rate +103.8%)
- EBITDA margin -774.0% increased compared to -1175.6% same period last year
- Net Debt increased by $2 bln since the start of the year (6279.1% of market cap)
- FCF (LTM) -$8.9 bln (negative), 27728.9% of market cap
- EV/Sales multiple is 6.9x

At the opening of the session the share price went up +3.3% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #FEMY

[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194247)
(2025-11-06, After Market Close):

- Revenue +31.4% YoY (vs +85.1% in previous quarter and historical rate +54.0%)
- EBITDA margin -489.4% increased compared to -908.5% same period last year
- Net Debt decreased by $776 mln over the past reporting period (7318.9% of market cap)
- FCF (LTM) -$5 bln (negative), 47233.2% of market cap
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #OMI

[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194224)
(2025-10-30, Before Market Open):

- Revenue -74.4% YoY (vs -74.5% in previous quarter and historical rate -9.6%)
- EBITDA +5.8% YoY (vs -76.2% in previous quarter and historical rate -20.5%)
- EBITDA margin 13.1% increased compared to 3.2% same period last year
- Net Debt increased by $144 mln over the past reporting period (81.2% of market cap)
- FCF (LTM) +$0.1 bln (positive), 62.0% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -1.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #HSON

[Hudson Global](https://eninvs.com/all.php?name=HSON) (Staffing and Employment Services) reported for 2025 q3
(2025-08-08, Before Market Open):

- Revenue +29.7% YoY (vs 0.0% in previous quarter and historical rate +7.8%)
- EBITDA margin -4.2% decreased compared to 0.0% same period last year
- Net Debt increased by $24 mln over the past reporting period (90.7% of market cap)
- EV/Sales multiple is 0.2x

At the opening of the session the share price went up +3.1% vs S&P500 +0.2%

------------------------------------------------

2025-11-15

#reports #XTNT

[Xtant Medical](https://eninvs.com/all.php?name=XTNT) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194103)
(2025-11-03, Before Market Open):

- Revenue +17.9% YoY (vs +16.7% in previous quarter and historical rate +35.7%)
- EBITDA margin 12.1% increased compared to -10.7% same period last year
- Net Debt decreased by $27 mln over the past reporting period (29.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 33.3x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.1% vs S&P500 +0.6%

------------------------------------------------

2025-11-15

#reports #XBIO

[Xenetic Biosciences](https://eninvs.com/all.php?name=XBIO) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194100)
(2025-08-12, Before Market Open):

- Revenue +67.3% YoY (vs -18.7% in previous quarter and historical rate +49.9%)
- EBITDA margin -52.2% increased compared to -80.0% same period last year
- Net Debt increased by $658 mln over the past reporting period (16410.8% of market cap)
- FCF (LTM) -$2.1 bln (negative), 51377.2% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is -1.4x

------------------------------------------------

2025-11-15

#reports #VRME

[VerifyMe](https://eninvs.com/all.php?name=VRME) (Security and Protection Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194099)
(2025-11-05, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +31.2%)
- Net Debt increased by $1 mln over the past reporting period (9.9% of market cap)
- FCF (LTM) +$0 bln (positive), 69.3% of market cap
- EV/EBITDA multiple is 0.6x compared to historical level (75th percentile) of 1.2x
- EV/Sales multiple is 0.3x

At the opening of the session the share price went up +2.2% vs S&P500 -0.1%

------------------------------------------------

2025-11-15

#reports #UTMD

[Utah Medical Products](https://eninvs.com/all.php?name=UTMD) (Medical Instruments and Supplies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194098)
(2025-05-15, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +3.0%)
- EBITDA +66.7% YoY (vs 0.0% in previous quarter and historical rate -2.0%)
- EBITDA margin 50.0% increased compared to 30.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.3 bln (positive), 151.8% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 12.1x
- EV/Sales multiple is 3x

At the opening of the session the share price went up +1.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #TPIC

[TPI Composites](https://eninvs.com/all.php?name=TPIC) (Industrial company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194096)
(2025-08-11, After Market Close):

- Revenue -38.6% YoY (vs -11.0% in previous quarter and historical rate -9.8%)
- EBITDA margin -33.3% decreased compared to -1.0% same period last year
- Net Debt decreased by $147 mln over the past reporting period (2432.0% of market cap)
- FCF (LTM) -$0 bln (negative), 165.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -23.3% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #TELA

[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194092)
(2025-11-13, After Market Close):

- Revenue +10.5% YoY (vs +25.0% in previous quarter and historical rate +29.5%)
- EBITDA margin -33.3% increased compared to -47.4% same period last year
- Net Debt increased by $43 mln over the past reporting period (94.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 121.3% of market cap
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -5.4% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #SMWB

[Similarweb Ltd.](https://eninvs.com/all.php?name=SMWB) (Internet Content and Information) reported for 2025 q3
(2025-11-11, After Market Close):

- Revenue +10.8% YoY (vs +16.4% in previous quarter and historical rate +14.0%)
- EBITDA margin -4.2% decreased compared to -3.1% same period last year
- Net Debt decreased by $5 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 1.9x

At the opening of the session the share price went down -15.1% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #SBH

[Sally Beauty](https://eninvs.com/all.php?name=SBH) (Professional cosmetics supplier ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194083)
(2025-11-13, Before Market Open):

- Revenue +1.3% YoY (vs -1.0% in previous quarter and historical rate -1.0%)
- EBITDA -2.4% YoY (vs +3.0% in previous quarter and historical rate +6.1%)
- EBITDA margin 8.4% decreased compared to 8.8% same period last year
- Net Debt increased by $16 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.7 bln (positive), 47.4% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 8x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +6.8% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #RKDA

[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194081)
(2025-11-07, After Market Close):

- Revenue -50% YoY (vs 0.0% in previous quarter and historical rate -21.5%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (38.8% of market cap)
- FCF (LTM) -$0 bln (negative), 77.7% of market cap
- EV/Sales multiple is -0.2x

At the opening of the session the share price went down -2.7% vs S&P500 +1.1%

------------------------------------------------

2025-11-15

#reports #REKR

[Rekor Systems](https://eninvs.com/all.php?name=REKR) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194079)
(2025-11-13, After Market Close):

- Revenue +27.3% YoY (vs 0.0% in previous quarter and historical rate +45.7%)
- EBITDA margin -21.4% increased compared to -109.1% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 3.8% of market cap
- EV/Sales multiple is 2.5x

At the opening of the session the share price went down -4.4% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #QUIK

[QuickLogic Corporation](https://eninvs.com/all.php?name=QUIK) (Semiconductors) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194076)
(2025-11-11, After Market Close):

- Revenue -50% YoY (vs 0.0% in previous quarter and historical rate +9.3%)
- EBITDA margin -150.0% decreased compared to -25.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) +$0 bln (positive), 6.2% of market cap
- EV/Sales multiple is 6x

At the opening of the session the share price went down -5.7% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #PXLW

[Pixelworks](https://eninvs.com/all.php?name=PXLW) (Semiconductors) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194073)
(2025-11-11, After Market Close):

- Revenue -10% YoY (vs -11.1% in previous quarter and historical rate -17.2%)
- EBITDA margin -55.6% increased compared to -80.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 2.4% of market cap
- EV/Sales multiple is 12.7x

At the opening of the session the share price went up +3.8% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #PRPO

[Precipio](https://eninvs.com/all.php?name=PRPO) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194071)
(2025-08-13, After Market Close):

- Revenue +40% YoY (vs +20.0% in previous quarter and historical rate +59.2%)
- EV/Sales multiple is 20.5x

At the opening of the session the share price went up +0.8% vs S&P500 -0.2%

------------------------------------------------

2025-11-15

#reports #NUWE

[Nuwellis](https://eninvs.com/all.php?name=NUWE) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194064)
(2025-08-14):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -150.0% decreased compared to -50.0% same period last year
- Net Debt decreased by $13 mln over the past reporting period (110.1% of market cap)
- FCF (LTM) -$0 bln (negative), 110.1% of market cap
- EV/Sales multiple is 2.2x

------------------------------------------------

2025-11-15

#reports #MYSZ

[My Size](https://eninvs.com/all.php?name=MYSZ) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194062)
(2025-08-14):

- Revenue +50% YoY (vs 0.0% in previous quarter and historical rate +59.7%)
- EBITDA margin -33.3% increased compared to -50.0% same period last year
- EV/Sales multiple is -0.1x

------------------------------------------------

2025-11-15

#reports #LPSN

[LivePerson](https://eninvs.com/all.php?name=LPSN) (Software provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194054)
(2025-11-05, After Market Close):

- Revenue -18.9% YoY (vs -25.0% in previous quarter and historical rate -17.4%)
- EBITDA margin -15.0% decreased compared to -9.5% same period last year
- Net Debt decreased by $80 mln over the past reporting period (253.9% of market cap)
- FCF (LTM) -$0 bln (negative), 152.3% of market cap
- EV/Sales multiple is 1.3x

At the opening of the session the share price went up +2.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #KPTI

[Karyopharm Therapeutics](https://eninvs.com/all.php?name=KPTI) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194051)
(2025-08-11, Before Market Open):

- Revenue +12.8% YoY (vs -11.6% in previous quarter and historical rate -8.9%)
- EBITDA margin -31.8% increased compared to -66.7% same period last year
- Net Debt increased by $12 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0.1 bln (negative), 11.7% of market cap
- EV/Sales multiple is 6x

At the opening of the session the share price went up +1.5% vs S&P500 0.0%

------------------------------------------------

2025-11-15

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194045)
(2025-11-06, Before Market Open):

- Revenue +32.6% YoY (vs -9.6% in previous quarter and historical rate -6.8%)
- EBITDA +181.5% YoY (vs +80.0% in previous quarter and historical rate +1.2%)
- EBITDA margin 62.3% increased compared to 29.3% same period last year
- Net Debt decreased by $247 mln over the past reporting period (51.1% of market cap)
- FCF (LTM) -$0.2 bln (negative), 36.8% of market cap
- EV/EBITDA multiple is 5x compared to historical level (75th percentile) of 7.1x
- EV/Sales multiple is 2.8x

At the opening of the session the share price went down -0.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #IRIX

[IRIDEX Corporation](https://eninvs.com/all.php?name=IRIX) (Medical Devices) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194044)
(2025-11-11, After Market Close):

- Revenue 0% YoY (vs +7.7% in previous quarter and historical rate -1.9%)
- EBITDA margin -8.3% increased compared to -16.7% same period last year
- Net Debt increased by $1 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) -$0 bln (negative), 30.4% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went down -12.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #INTZ

[Intrusion](https://eninvs.com/all.php?name=INTZ) (Software — Infrastructure) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194039)
(2025-08-12, After Market Close):

- Revenue 0% YoY (vs +100.0% in previous quarter and historical rate +16.7%)
- EBITDA margin -100.0% has not changed compared to -100.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (133.4% of market cap)
- FCF (LTM) +$0 bln (positive), 133.4% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +2.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #HZO

[MarineMax](https://eninvs.com/all.php?name=HZO) (Specialty Retail) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=HZO&q=2025 q3&id=902155)
(2025-11-13, Before Market Open):

- Revenue -2% YoY (vs -13.3% in previous quarter and historical rate +0.3%)
- EBITDA -49.1% YoY (vs -139.2% in previous quarter and historical rate -10.9%)
- EBITDA margin 4.9% decreased compared to 9.4% same period last year
- Net Debt decreased by $47 mln over the past reporting period (9.1% of market cap)
- FCF (LTM) -$0.1 bln (negative), 22.2% of market cap
- EV/EBITDA multiple is 19.1x compared to historical level (75th percentile) of 10.2x
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -1.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #HYFM

[Hydrofarm Holdings Group, Inc.](https://eninvs.com/all.php?name=HYFM) (Farm and Heavy Construction Machinery) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194034)
(2025-08-12):

- Revenue -34.1% YoY (vs -29.1% in previous quarter and historical rate -27.3%)
- EBITDA -200% YoY (vs -1200.0% in previous quarter and historical rate +56.6%)
- EBITDA margin -6.9% decreased compared to 4.5% same period last year
- Net Debt decreased by $2 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 6.1% of market cap
- EV/EBITDA multiple is 58.3x compared to historical level (75th percentile) of 160.5x
- EV/Sales multiple is 1.6x

------------------------------------------------

2025-11-15

#reports #FWRD

[Forward Air](https://eninvs.com/all.php?name=FWRD) (Transportation services provider) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194031)
(2025-11-05, After Market Close):

- Revenue -3.7% YoY (vs -3.9% in previous quarter and historical rate +13.7%)
- EBITDA +8.2% YoY (vs +5500.0% in previous quarter and historical rate +10.9%)
- EBITDA margin 8.4% increased compared to 7.5% same period last year
- Net Debt decreased by $60 mln over the past reporting period (10.5% of market cap)
- FCF (LTM) +$1.7 bln (positive), 302.5% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 1.1x

At the opening of the session the share price went up +24.0% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #FTHM

[Fathom](https://eninvs.com/all.php?name=FTHM) (Real Estate Services) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194030)
(2025-11-11, After Market Close):

- Revenue +36.9% YoY (vs +536.8% in previous quarter and historical rate +9.8%)
- EBITDA margin -0.9% increased compared to -6.0% same period last year
- Net Debt decreased by $9 mln over the past reporting period (32.1% of market cap)
- FCF (LTM) -$0 bln (negative), 32.1% of market cap
- EV/Sales multiple is 0.1x

At the opening of the session the share price went down -12.1% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #FTCI

[FTC Solar, Inc.](https://eninvs.com/all.php?name=FTCI) (Solar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194029)
(2025-08-05, Before Market Open):

- Revenue +160% YoY (vs +81.8% in previous quarter and historical rate +3.3%)
- EBITDA margin -26.9% increased compared to -150.0% same period last year
- Net Debt increased by $33 mln over the past reporting period (2.4% of market cap)
- FCF (LTM) -$0 bln (negative), 1.1% of market cap
- EV/Sales multiple is 17.5x

At the opening of the session the share price went down -15.3% vs S&P500 +0.1%

------------------------------------------------

2025-11-15

#reports #FF

[FutureFuel](https://eninvs.com/all.php?name=FF) (Chemicals) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194025)
(2025-11-10, After Market Close):

- Revenue -54.9% YoY (vs -50.0% in previous quarter and historical rate -22.0%)
- EBITDA margin -34.8% decreased compared to -2.0% same period last year
- Net Debt increased by $8 mln over the past reporting period (5.4% of market cap)
- FCF (LTM) -$0 bln (negative), 24.5% of market cap
- EV/Sales multiple is 0.5x

At the opening of the session the share price went up +0.1% vs S&P500 -0.3%

------------------------------------------------

2025-11-15

#reports #FBIOP

[Fortress Biotech](https://eninvs.com/all.php?name=FBIOP) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194024)
(2025-08-14):

- Revenue +20% YoY (vs +6.7% in previous quarter and historical rate +2.9%)
- EBITDA +115.4% YoY (vs -3700.0% in previous quarter and historical rate +39.8%)
- EBITDA margin 155.6% increased compared to 86.7% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) -$0 bln (negative), 5.3% of market cap
- EV/Sales multiple is 2.9x

------------------------------------------------

2025-11-15

#reports #DXYN

[The Dixie Group](https://eninvs.com/all.php?name=DXYN) (Textile Manufacturing) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194019)
(2025-11-07, Before Market Open):

- Revenue -4.6% YoY (vs -2.8% in previous quarter and historical rate -7.0%)
- EBITDA margin -3.2% decreased compared to -3.1% same period last year
- Net Debt decreased by $2 mln over the past reporting period (24.2% of market cap)
- FCF (LTM) +$0 bln (positive), 72.6% of market cap
- EV/EBITDA multiple is 112.3x compared to historical level (75th percentile) of 17.4x
- EV/Sales multiple is 0.4x

At the opening of the session the share price went up +1.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #DRIO

[DarioHealth](https://eninvs.com/all.php?name=DRIO) (Diagnostics and Research) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194017)
(2025-11-13, Before Market Open):

- Revenue -28.6% YoY (vs -16.7% in previous quarter and historical rate +19.5%)
- EBITDA -16.7% YoY (vs -47.1% in previous quarter and historical rate +47.9%)
- EBITDA margin 200.0% increased compared to 171.4% same period last year
- Net Debt decreased by $35 mln over the past reporting period (6.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 12.4% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 21.9x
- EV/Sales multiple is 20x

At the opening of the session the share price went down -4.5% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #DAIO

[Data I/O Corporation](https://eninvs.com/all.php?name=DAIO) (Electronic Components) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194013)
(2025-10-30, After Market Close):

- Revenue 0% YoY (vs +20.0% in previous quarter and historical rate +1.4%)
- EBITDA margin -20.0% decreased compared to 0.0% same period last year
- EV/Sales multiple is 0.7x

At the opening of the session the share price went down -2.2% vs S&P500 +0.8%

------------------------------------------------

2025-11-15

#reports #BKTI

[BK Technologies Corporation](https://eninvs.com/all.php?name=BKTI) (Communication Equipment) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=194001)
(2025-11-06, Before Market Open):

- Revenue +20% YoY (vs +5.0% in previous quarter and historical rate +31.1%)
- EBITDA +66.7% YoY (vs +100.0% in previous quarter)
- EBITDA margin 20.8% increased compared to 15.0% same period last year
- Net Debt decreased by $10 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 72.7x compared to historical level (75th percentile) of 93.6x
- EV/Sales multiple is 13.3x

At the opening of the session the share price went down -1.7% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #BFRI

[Biofrontera Inc.](https://eninvs.com/all.php?name=BFRI) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193998)
(2025-08-13, Before Market Open):

- Revenue -22.2% YoY (vs +12.5% in previous quarter and historical rate +29.1%)
- EBITDA margin -85.7% decreased compared to -55.6% same period last year
- Net Debt increased by $4 mln over the past reporting period (18.3% of market cap)
- FCF (LTM) +$0 bln (positive), 27.5% of market cap
- EV/Sales multiple is 0.4x

At the opening of the session the share price went down -2.2% vs S&P500 +0.3%

------------------------------------------------

2025-11-15

#reports #BBGI

[Beasley Broadcast Group](https://eninvs.com/all.php?name=BBGI) (Broadcasting) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193994)
(2025-11-10, Before Market Open):

- Revenue -12.4% YoY (vs -12.3% in previous quarter and historical rate -4.8%)
- EBITDA -57.8% YoY (vs -40.6% in previous quarter and historical rate +42.1%)
- EBITDA margin 1.9% decreased compared to 4.0% same period last year
- Net Debt decreased by $5.5 bln since the start of the year (4514.2% of market cap)
- FCF (LTM) +$5.3 bln (positive), 4343.7% of market cap
- EV/EBITDA multiple is 18x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 1.2x

At the opening of the session the share price went down -15.1% vs S&P500 +1.1%

------------------------------------------------

2025-11-15

#reports #AWH

[Aspira Women's Health](https://eninvs.com/all.php?name=AWH) (Treatments for gynecological problems developer ) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193992)
(2023-08-14, Before Market Open):

- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate 0.0%)
- EBITDA margin -100.0% increased compared to -200.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (264.1% of market cap)
- EV/Sales multiple is 0.7x

At the opening of the session the share price went up +0.6%

------------------------------------------------

2025-11-15

#reports #ATNI

[ATN International](https://eninvs.com/all.php?name=ATNI) (Telecommunications company) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193985)
(2025-11-05, After Market Close):

- Revenue +2.8% YoY (vs -1.1% in previous quarter and historical rate +27.8%)
- EBITDA margin 24.0% increased compared to 0.6% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 7.6% of market cap
- EV/EBITDA multiple is 7.4x compared to historical level (75th percentile) of 11x
- EV/Sales multiple is 0.9x

At the opening of the session the share price went up +6.3% vs S&P500 -0.4%

------------------------------------------------

2025-11-15

#reports #AGEN

[Agenus](https://eninvs.com/all.php?name=AGEN) (Biotechnology) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193979)
(2025-11-10, Before Market Open):

- Revenue +20% YoY (vs +8.3% in previous quarter and historical rate +18.3%)
- EBITDA margin -6.7% increased compared to -112.0% same period last year
- Net Debt decreased by $69 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.0% of market cap
- EV/Sales multiple is 16.3x

------------------------------------------------

2025-11-15

#reports #ADES

[Advanced Emissions Solutions](https://eninvs.com/all.php?name=ADES) (Pollution and Treatment Controls) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193977)
(2023-11-08, After Market Close):

- Revenue 0% YoY (vs +16.0% in previous quarter and historical rate +21.0%)
- EBITDA -14.3% YoY (vs +50.0% in previous quarter)
- EBITDA margin 17.1% decreased compared to 20.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 36.6% of market cap
- EV/EBITDA multiple is 22.6x compared to historical level (75th percentile) of 29.3x
- EV/Sales multiple is 0.8x

At the opening of the session the share price went up +0.5%

------------------------------------------------

2025-11-15

#reports #BEEM
@ renewable-energy

[Beam Global](https://eninvs.com/all.php?name=BEEM) (Solar) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193997)
(2025-11-13, After Market Close):

- Revenue -45.5% YoY (vs -53.3% in previous quarter and historical rate +49.5%)
- EBITDA -300% YoY (vs -500.0% in previous quarter)
- EBITDA margin -66.7% decreased compared to 18.2% same period last year
- EV/Sales multiple is 1x

At the opening of the session the share price went down -2.8% vs S&P500 -1.1%

------------------------------------------------

2025-11-15

#reports #SE
@ gaming

[Sea](https://eninvs.com/all.php?name=SE) (Electronic Gaming and Multimedia) reported for [2025 q3](https://eninvs.com/press_release.php?ticker=SE&q=2025 q3&id=901650)
(2025-11-11, Before Market Open):

- Revenue +38.3% YoY (vs +38.1% in previous quarter and historical rate +20.5%)
- EBITDA +121.2% YoY (vs +279.3% in previous quarter and historical rate +109.2%)
- EBITDA margin 8.4% increased compared to 5.2% same period last year
- Net Debt decreased by $439 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$1.7 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 39.6x compared to historical level (75th percentile) of 133.4x
- EV/Sales multiple is 3.5x

At the opening of the session the share price went up +2.4% vs S&P500 -0.3%

------------------------------------------------

2025-11-13

#reports #TTEK

[Tetra Tech](https://eninvs.com/all.php?name=TTEK) (Consulting company) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue -3.2% YoY (vs +1.9% in previous quarter and historical rate +19.0%)
- EBITDA +22.5% YoY (vs +20.9% in previous quarter and historical rate +7.0%)
- EBITDA margin 14.7% increased compared to 11.6% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 23.5x
- EV/Sales multiple is 0.5x

------------------------------------------------

2025-11-13

#reports #SSTI

[ShotSpotter](https://eninvs.com/all.php?name=SSTI) (Software — Application) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue -3.8% YoY (vs -3.7% in previous quarter and historical rate +17.6%)
- EBITDA margin -8.0% decreased compared to -3.8% same period last year
- Net Debt decreased by $3 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0 bln (negative), 6.8% of market cap
- EV/Sales multiple is 0.9x

------------------------------------------------

2025-11-13

#reports #RSKD

[Riskified Ltd.](https://eninvs.com/all.php?name=RSKD) (Software — Application) reported for 2025 q3
(2025-11-12, Before Market Open):

- Revenue +3.8% YoY (vs +2.5% in previous quarter and historical rate +10.3%)
- EBITDA margin -6.1% increased compared to -12.7% same period last year
- Net Debt increased by $14 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 7.8% of market cap
- EV/Sales multiple is 1.5x

At the opening of the session the share price went up +1.8% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #IDN

[Intellicheck](https://eninvs.com/all.php?name=IDN) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193955)
(2025-11-05, After Market Close):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate +29.4%)
- Net Debt increased by $1 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 3.5% of market cap
- EV/EBITDA multiple is 76.5x compared to historical level (75th percentile) of 46x
- EV/Sales multiple is 2.5x

At the opening of the session the share price went up +0.2% vs S&P500 -0.4%

------------------------------------------------

2025-11-13

#reports #EWCZ

[European Wax Center, Inc.](https://eninvs.com/all.php?name=EWCZ) (Household and Personal Products) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193953)
(2025-11-12, Before Market Open):

- Revenue -1.8% YoY (vs -6.7% in previous quarter and historical rate +17.6%)
- EBITDA +26.7% YoY (vs 0.0% in previous quarter and historical rate +25.2%)
- EBITDA margin 35.2% increased compared to 27.3% same period last year
- Net Debt decreased by $12 mln over the past reporting period (4.4% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 21x
- EV/Sales multiple is 2.9x

At the opening of the session the share price went up +9.6% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #EGAN

[eGain](https://eninvs.com/all.php?name=EGAN) (Software — Application) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193950)
(2025-09-04, After Market Close):

- Revenue +9.1% YoY (vs -67.1% in previous quarter and historical rate +8.1%)
- EBITDA margin 12.5% increased compared to 4.5% same period last year
- Net Debt decreased by $9 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 28.7x compared to historical level (75th percentile) of 32.4x
- EV/Sales multiple is 3.8x

At the opening of the session the share price went up +2.1% vs S&P500 +0.4%

------------------------------------------------

2025-11-13

#reports #DGII

[Digi International](https://eninvs.com/all.php?name=DGII) (Communication Equipment) reported for 2025 q3
(2025-11-12, After Market Close):

- Revenue +8.6% YoY (vs +2.9% in previous quarter and historical rate +4.1%)
- EBITDA -7.7% YoY (vs +8.7% in previous quarter)
- EBITDA margin 10.5% decreased compared to 12.4% same period last year
- Net Debt increased by $117 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 20.9x
- EV/Sales multiple is 3.4x

------------------------------------------------

2025-11-13

#reports #DERM

[Journey Medical Corporation](https://eninvs.com/all.php?name=DERM) (Drug Manufacturers — Specialty and Generic) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193948)
(2025-11-05, After Market Close):

- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate -4.3%)
- EBITDA margin -5.6% increased compared to -13.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 3.8% of market cap
- EV/Sales multiple is 3.1x

At the opening of the session the share price went up +1.4% vs S&P500 -0.4%

------------------------------------------------

2025-11-13

#reports #CCRN

[Cross Country Healthcare](https://eninvs.com/all.php?name=CCRN) (Medical Care Facilities) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193944)
(2025-11-03, After Market Close):

- Revenue -20.6% YoY (vs -19.4% in previous quarter and historical rate -25.7%)
- EBITDA -128.6% YoY (vs -300.0% in previous quarter and historical rate -67.7%)
- EBITDA margin -0.8% decreased compared to 2.2% same period last year
- Net Debt decreased by $19 mln over the past reporting period (4.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.2% of market cap
- EV/Sales multiple is 0.3x

At the opening of the session the share price went down -0.7% vs S&P500 -0.9%

------------------------------------------------

2025-11-13

#reports #AP

[Ampco-Pittsburgh Corporation](https://eninvs.com/all.php?name=AP) (Metal Fabrication) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193940)
(2025-11-12, After Market Close):

- Revenue +12.5% YoY (vs +1.8% in previous quarter and historical rate +4.0%)
- EBITDA -89.7% YoY (vs -80.0% in previous quarter and historical rate +39.6%)
- EBITDA margin 7.4% decreased compared to 81.3% same period last year
- Net Debt decreased by $4 mln over the past reporting period (10.4% of market cap)
- FCF (LTM) -$0 bln (negative), 13.0% of market cap
- EV/EBITDA multiple is 1.7x compared to historical level (75th percentile) of 8.3x
- EV/Sales multiple is 0.4x

------------------------------------------------

2025-11-13

#reports #HUYA
@ china , @ gaming

[HUYA](https://eninvs.com/all.php?name=HUYA) (Entertainment) reported for 2025 q3
(2025-11-12, Before Market Open):

- Revenue +8.2% YoY (vs +3.3% in previous quarter and historical rate -13.7%)
- EBITDA +4.9% YoY (vs -400.0% in previous quarter and historical rate +18.7%)
- EBITDA margin 27.0% decreased compared to 27.9% same period last year
- Net Debt decreased by $41 mln over the past reporting period (6.4% of market cap)
- FCF (LTM) -$0.4 bln (negative), 69.5% of market cap
- EV/EBITDA multiple is 1.9x compared to historical level (75th percentile) of 4.3x
- EV/Sales multiple is 0.1x

At the opening of the session the share price went up +2.9% vs S&P500 +0.3%

------------------------------------------------

2025-11-13

#reports #GWRS

[Global Water Resources](https://eninvs.com/all.php?name=GWRS) (Utilities — Regulated Water) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193930)
(2025-11-13, Before Market Open):

- Revenue +14.3% YoY (vs 0.0% in previous quarter and historical rate +16.5%)
- EBITDA +42.9% YoY (vs 0.0% in previous quarter and historical rate +7.5%)
- EBITDA margin 62.5% increased compared to 50.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 16.5x compared to historical level (75th percentile) of 19.3x
- EV/Sales multiple is 5.9x

------------------------------------------------

2025-11-11

#reports #TSQ

[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193926)
(2025-11-10, Before Market Open):

- Revenue -7% YoY (vs -2.5% in previous quarter and historical rate -1.0%)
- EBITDA -25% YoY (vs +2500.0% in previous quarter and historical rate +14.8%)
- EBITDA margin 14.0% decreased compared to 17.4% same period last year
- Net Debt decreased by $1 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0 bln (positive), 22.7% of market cap
- EV/EBITDA multiple is 6.9x compared to historical level (75th percentile) of 17.5x
- EV/Sales multiple is 1.3x

At the opening of the session the share price went down -2.6% vs S&P500 +1.1%

------------------------------------------------

2025-11-11

#reports #TBPH

[Theravance Biopharma](https://eninvs.com/all.php?name=TBPH) (Biotechnology) reported for 2025 q3
(2025-11-10, After Market Close):

- Revenue +17.6% YoY (vs +85.7% in previous quarter and historical rate +34.8%)
- EBITDA margin -30.0% increased compared to -58.8% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 23.2% of market cap
- EV/EBITDA multiple is 135.6x compared to historical level (75th percentile) of 362x
- EV/Sales multiple is 10.2x

------------------------------------------------

2025-11-11

#reports #SIBN

[SI-BONE](https://eninvs.com/all.php?name=SIBN) (Medical device manufacturer) reported for [2025 q3](https://eninvs.com/press_release.php?source=sec&form_type=10&id=193924)
(2025-11-10, After Market Close):

- Revenue +22.5% YoY (vs +22.5% in previous quarter and historical rate +25.5%)
- EBITDA margin -10.2% increased compared to -17.5% same period last year
- EV/Sales multiple is 2.2x

At the opening of the session the share price went up +0.5%

Switch to company model in classical logic    *